1. Home
  2. SLBT vs PAHC Comparison

SLBT vs PAHC Comparison

Compare SLBT & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SL Science Holding Limited Ordinary Shares

SLBT

SL Science Holding Limited Ordinary Shares

N/A

Current Price

$2.65

Market Cap

1.5B

Sector

N/A

ML Signal

N/A

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

HOLD

Current Price

$36.33

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLBT
PAHC
Founded
N/A
1946
Country
Taiwan
United States
Employees
20
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
SLBT
PAHC
Price
$2.65
$36.33
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$41.25
AVG Volume (30 Days)
145.3K
241.2K
Earning Date
N/A
05-06-2026
Dividend Yield
N/A
0.91%
EPS Growth
N/A
1883.33
EPS
N/A
1.90
Revenue
N/A
$833,350,000.00
Revenue This Year
N/A
$17.03
Revenue Next Year
N/A
$3.82
P/E Ratio
N/A
$19.14
Revenue Growth
N/A
4.12
52 Week Low
$2.54
$26.08
52 Week High
$6.25
$60.08

Technical Indicators

Market Signals
Indicator
SLBT
PAHC
Relative Strength Index (RSI) 35.84 60.54
Support Level N/A $30.55
Resistance Level $4.91 $42.82
Average True Range (ATR) 0.37 1.22
MACD -0.14 0.41
Stochastic Oscillator 7.91 66.81

Price Performance

Historical Comparison
SLBT
PAHC

About SLBT SL Science Holding Limited Ordinary Shares

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: